Optima Health has provided a trading update for the 12 months to end March 2026, reporting revenue of c£121m (+15% YoY), in line with market expectations, alongside adjusted EBITDA expected to be c10% ahead of previous market expectations, as previously guided. Operationally, the year was defined by the transformational £100m acquisition of PAM Healthcare, completed in March 2026, significantly enhancing the group’s scale and capabilities. Integration is progressing well, with £1.3m of annualise ....
